Daraxonrasib wins FDA approval for advanced pancreatic cancer
Daraxonrasib wins FDA approval for advanced pancreatic cancerThe Food and Drug Administration on Wednesday, August 26, approved a groundbreaking new drug for advanced pancreatic cancer that offers double survival time against one of the deadliest forms of cancer.
The one-day pill,...
0

0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.